Abreos Biosciences
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3550 General Atomics Ct Bldg G2 Rm 559, ...Phone Number
(858) 248-9253Website
www.abreos.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Abreos Biosciences
Abreos Biosciences, a San Diego-based biotech company was founded in 2013 by CEO Dr. Bradley Messmer and is focused on developing technologies in precision medicine using their proprietary Veritope platform. By simply monitoring biologics in blood, Abreos has developed a portfolio of applications built with the patient in mind to ensure that patients are on the right therapies at the right dose. Point-of-care devices are also available for clinical testing.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abreos Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Abreos Biosciences is spiking on competitors!
Click to see if Abreos Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Abreos Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Abreos Biosciences launches new products
Check if Abreos Biosciences has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Abreos Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Abreos Biosciences
Earning: See what the market has to say on Abreos Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Abreos Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Abreos Biosciences
Compare insights from companies similar to Abreos Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Abreos Biosciences
<$5M
1-10
Private
<$5M
2013
N/A
Company Profile Activity
Activity Insights
Abreos Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Abreos Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Abreos Biosciences.
Abreos Biosciences financials insights
Gather financial insights about Abreos Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$725K
2017
Private Equity
$1.2M
Abreos Biosciences Tech Stack
A closer look at the technologies used by Abreos Biosciences
Abreos Biosciences News & Media
Abreos Biosciences Announces Partnership with CLIA/CAP Certified Laboratory, ResearchDx
Commercial assay for Tysabri (Natalizumab) developed to enable physicians to make data driven decisions on how to optimize the infusion schedule for their multiple sclerosis patients. (PRWeb August 30, 2018) Read the full story at https://www.prweb.com/releases/abreos_biosciences_announces_partnership_with_clia_cap_certified_laboratory_researchdx/prweb15726409.htmAbreos Biosciences Launches Laboratory Developed Test for Precision Dose Monitoring of Natalizumab (Tysabri)
Novel assay addresses substantial unmet need for physicians to more effectively monitor biologic drug levels in patients. (PRWeb August 22, 2018) Read the full story at https://www.prweb.com/releases/abreos_biosciences_launches_laboratory_developed_test_for_precision_dose_monitoring_of_natalizumab_tysabri/prweb15705476.htm
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abreos Biosciences
Sign Up For FreeTo access detailed company insights
Abreos Biosciences, a San Diego-based biotech company was founded in 2013 by CEO Dr. Bradley Messmer and is focused on developing technologies in precision medicine using their proprietary Veritope platform. By simply monitoring biologics in blood, Abreos has developed a portfolio of applications built with the patient in mind to ensure that patien... Read More
